Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells.
about
Therapeutic Value of Voltage-Gated Sodium Channel Inhibitors in Breast, Colorectal, and Prostate Cancer: A Systematic ReviewSodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the CPRD primary care databaseBRCA-Monet: a breast cancer specific drug treatment mode-of-action network for treatment effective prediction using large scale microarray database.Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.The correlation between telomerase activity and Bax/Bcl-2 ratio in valproic acid-treated MCF-7 breast cancer cell lineValproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylationRepurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma.VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin.CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status.The role and possible molecular mechanism of valproic acid in the growth of MCF-7 breast cancer cells.Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells.
P2860
Q26772803-003455B4-1496-4C8A-8AD1-384A5FCBB4DBQ28595847-CA514DB8-6E73-47DE-917C-2A5E17CB2A87Q33643334-ADC9B5CE-6A3F-4018-B851-CB29C9154988Q35845089-8016E057-6335-4341-80F9-08E76C6C5AA1Q36017178-DADAD371-A5DB-436B-A0A1-6940B82C8770Q36335796-62A5A32F-36D5-4A9A-9D38-A6FF2DC328ADQ36380213-ADE36BD1-A53C-45BD-8D13-9452689C25D6Q39465533-64605DC6-0545-430B-89A8-412BFE19D600Q39616031-93DE1266-BE60-4266-89FA-C96A7C9714A3Q47136713-16A129B1-D392-4092-B996-AA3C50F61ECCQ49544302-6AA8830D-6A31-4B22-9874-7411BABB346EQ51599902-3F9828EB-B3A0-4424-BB43-20EC72E1962D
P2860
Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Valproic acid is a selective a ...... sensitive breast cancer cells.
@en
type
label
Valproic acid is a selective a ...... sensitive breast cancer cells.
@en
prefLabel
Valproic acid is a selective a ...... sensitive breast cancer cells.
@en
P2093
P1433
P1476
Valproic acid is a selective a ...... sensitive breast cancer cells.
@en
P2093
Giuseppe Boccuzzi
Ilenia Vercellinatto
Lucia Costantino
Maria Graziella Catalano
Ornella Bosco
Silvia Bertino
P304
P356
10.1016/J.CANLET.2007.10.006
P407
P577
2007-11-19T00:00:00Z